Active — Not RecruitingNot Applicable

Antihypertensive and PAP Treatment in Obstructive Sleep Apnea Patients With Hypertension (AHPAP)

Sweden10,000 participantsStarted 2008-01

Plain-language summary

The investigators will perform a long term registry based prospective analysis on incidence of major cardiovascular events or death in hypertensive patients with obstructive sleep apnea . Effects of PAP (positive airway pressure) compliance, antihypertensive medication and blood pressure control will be investigated in the study.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All hypertensive and obstructive sleep apnea patients present in QregPV and SESAR 2008-2021. Exclusion Criteria: * Patients in the hypertensive control group (without OSA) will be excluded if they have OSA diagnosis but are not present in the SESAR registry. * Subjects with missing data on any of the variables in the fitted model unless the missing data can be accurately imputated. * Patients with low life expectancy (Age\>75 at study start, malignant disease). * Patients no longer living in VGR 2021.

What they're measuring

Major cardiovascular event (MCE) or death

Timeframe: First incidence during study, ie within 156 months (13 yrs) maximum

Trial details

NCT IDNCT05115994

SponsorVastra Gotaland Region

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2026-06

View on ClinicalTrials.gov More Obstructive Sleep Apnea trials